COGT
Price
$4.81
Change
-$0.17 (-3.41%)
Updated
May 9 closing price
Capitalization
547.65M
94 days until earnings call
ETXPF
Price
$0.13
Change
-$0.01 (-7.14%)
Updated
Apr 16 closing price
Capitalization
75.96M
Ad is loading...

COGT vs ETXPF

Header iconCOGT vs ETXPF Comparison
Open Charts COGT vs ETXPFBanner chart's image
Cogent Biosciences
Price$4.81
Change-$0.17 (-3.41%)
Volume$708.72K
Capitalization547.65M
E-Therapeutics
Price$0.13
Change-$0.01 (-7.14%)
Volume$10K
Capitalization75.96M
COGT vs ETXPF Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. ETXPF commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and ETXPF is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (COGT: $4.81 vs. ETXPF: $0.13)
Brand notoriety: COGT and ETXPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 53% vs. ETXPF: 100%
Market capitalization -- COGT: $547.65M vs. ETXPF: $75.96M
COGT [@Biotechnology] is valued at $547.65M. ETXPF’s [@Biotechnology] market capitalization is $75.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileETXPF’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • ETXPF’s FA Score: 0 green, 5 red.
According to our system of comparison, both COGT and ETXPF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish.

  • COGT’s TA Score: 5 bullish, 3 bearish.

Price Growth

COGT (@Biotechnology) experienced а -18.06% price change this week, while ETXPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($548M) has a higher market cap than ETXPF($76M). ETXPF YTD gains are higher at: 0.000 vs. COGT (-38.333).
COGTETXPFCOGT / ETXPF
Capitalization548M76M721%
EBITDA-271.59MN/A-
Gain YTD-38.3330.000-
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash287MN/A-
Total Debt17.5MN/A-
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X102970.850000-270.609380
-0.26%
Bitcoin cryptocurrency

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-3.41%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-3.36%
ETNB - COGT
52%
Loosely correlated
-1.16%
XNCR - COGT
52%
Loosely correlated
-5.23%
ARWR - COGT
51%
Loosely correlated
-1.66%
More

ETXPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETXPF has been loosely correlated with MTVA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ETXPF jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETXPF
1D Price
Change %
ETXPF100%
N/A
MTVA - ETXPF
52%
Loosely correlated
+2.68%
TYRA - ETXPF
42%
Loosely correlated
+0.20%
KPRX - ETXPF
37%
Loosely correlated
+4.17%
COGT - ETXPF
33%
Poorly correlated
-3.41%
BRTX - ETXPF
24%
Poorly correlated
-1.13%
More